State Street’s Immunogen Inc IMGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-8,075,671
| Closed | -$239M | – | 4457 |
|
|
2023
Q4 | $239M | Sell |
8,075,671
-1,476,181
| -15% | -$29.4M | 0.01% | 747 |
|
|
2023
Q3 | $152M | Buy |
9,551,852
+1,612,938
| +20% | +$26.8M | 0.01% | 919 |
|
|
2023
Q2 | $150M | Sell |
7,938,914
-9,138,044
| -54% | -$108M | 0.01% | 969 |
|
|
2023
Q1 | $65.6M | Sell |
17,076,958
-431,155
| -2% | -$1.84M | ﹤0.01% | 1459 |
|
|
2022
Q4 | $86.8M | Buy |
17,508,113
+2,913,240
| +20% | +$15.8M | 0.01% | 1255 |
|
|
2022
Q3 | $69.8M | Sell |
14,594,873
-3,604,681
| -20% | -$19M | ﹤0.01% | 1357 |
|
|
2022
Q2 | $81.9M | Buy |
18,199,554
+4,492,165
| +33% | +$19.5M | ﹤0.01% | 1309 |
|
|
2022
Q1 | $65.2M | Buy |
13,707,389
+5,638,822
| +70% | +$31.2M | ﹤0.01% | 1593 |
|
|
2021
Q4 | $59.9M | Sell |
8,068,567
-997,290
| -11% | -$6.2M | ﹤0.01% | 1686 |
|
|
2021
Q3 | $51.4M | Sell |
9,065,857
-1,654,074
| -15% | -$9.56M | ﹤0.01% | 1790 |
|
|
2021
Q2 | $70.6M | Buy |
10,719,931
+1,696,452
| +19% | +$11.8M | ﹤0.01% | 1585 |
|
|
2021
Q1 | $73.1M | Buy |
9,023,479
+219,638
| +2% | +$1.79M | ﹤0.01% | 1469 |
|
|
2020
Q4 | $56.8M | Sell |
8,803,841
-160,165
| -2% | -$934K | ﹤0.01% | 1563 |
|
|
2020
Q3 | $32.3M | Sell |
8,964,006
-219,300
| -2% | -$885K | ﹤0.01% | 1753 |
|
|
2020
Q2 | $42.2M | Buy |
9,183,306
+3,457,441
| +60% | +$14.7M | ﹤0.01% | 1558 |
|
|
2020
Q1 | $19.5M | Buy |
5,725,865
+379,439
| +7% | +$1.66M | ﹤0.01% | 1851 |
|
|
2019
Q4 | $27.3M | Sell |
5,346,426
-862,921
| -14% | -$2.93M | ﹤0.01% | 1919 |
|
|
2019
Q3 | $15M | Buy |
6,209,347
+3,256,351
| +110% | +$8.65M | ﹤0.01% | 2244 |
|
|
2019
Q2 | $6.41M | Sell |
2,952,996
-9,694,748
| -77% | -$22.9M | ﹤0.01% | 2699 |
|
|
2019
Q1 | $34.3M | Buy |
12,647,744
+4,547,373
| +56% | +$19.7M | ﹤0.01% | 1678 |
|
|
2018
Q4 | $38.9M | Sell |
8,100,371
-831,141
| -9% | -$5.04M | ﹤0.01% | 1516 |
|
|
2018
Q3 | $84.6M | Sell |
8,931,512
-64,495
| -0.7% | -$620K | 0.01% | 1183 |
|
|
2018
Q2 | $87.5M | Buy |
8,996,007
+1,758,759
| +24% | +$18.5M | 0.01% | 1127 |
|
|
2018
Q1 | $76.1M | Sell |
7,237,248
-1,107,923
| -13% | -$10.9M | 0.01% | 1166 |
|
|
2017
Q4 | $53.5M | Buy |
8,345,171
+2,167,366
| +35% | +$13.4M | ﹤0.01% | 1390 |
|
|
2017
Q3 | $47.3M | Buy |
6,177,805
+2,036,222
| +49% | +$13.5M | ﹤0.01% | 1419 |
|
|
2017
Q2 | $29.4M | Buy |
4,141,583
+2,542,876
| +159% | +$11.6M | ﹤0.01% | 1709 |
|
|
2017
Q1 | $6.18M | Buy |
1,598,707
+72,309
| +5% | +$211K | ﹤0.01% | 2598 |
|
|
2016
Q4 | $3.12M | Buy |
1,526,398
+45,628
| +3% | +$91.6K | ﹤0.01% | 2915 |
|
|
2016
Q3 | $3.97M | Sell |
1,480,770
-1,561,271
| -51% | -$4.54M | ﹤0.01% | 2693 |
|
|
2016
Q2 | $9.37M | Buy |
3,042,041
+466,014
| +18% | +$2.92M | ﹤0.01% | 2260 |
|
|
2016
Q1 | $21.9M | Sell |
2,576,027
-43,635
| -2% | -$369K | ﹤0.01% | 1663 |
|
|
2015
Q4 | $35.5M | Sell |
2,619,662
-606,203
| -19% | -$7.46M | ﹤0.01% | 1352 |
|
|
2015
Q3 | $31M | Sell |
3,225,865
-43,838
| -1% | -$641K | ﹤0.01% | 1447 |
|
|
2015
Q2 | $47M | Sell |
3,269,703
-960,879
| -23% | -$10.6M | 0.01% | 1311 |
|
|
2015
Q1 | $37.9M | Buy |
4,230,582
+1,089,270
| +35% | +$7.89M | ﹤0.01% | 1398 |
|
|
2014
Q4 | $19.2M | Buy |
3,141,312
+326,266
| +12% | +$2.98M | ﹤0.01% | 1835 |
|
|
2014
Q3 | $29.8M | Buy |
2,815,046
+279,299
| +11% | +$3.16M | ﹤0.01% | 1448 |
|
|
2014
Q2 | $30M | Sell |
2,535,747
-75,896
| -3% | -$953K | ﹤0.01% | 1520 |
|
|
2014
Q1 | $39M | Buy |
2,611,643
+93,879
| +4% | +$1.48M | ﹤0.01% | 1348 |
|
|
2013
Q4 | $36.9M | Sell |
2,517,764
-117,555
| -4% | -$1.81M | ﹤0.01% | 1365 |
|
|
2013
Q3 | $44.9M | Buy |
2,635,319
+37,074
| +1% | +$652K | 0.01% | 1230 |
|
|
2013
Q2 | $43.1M | Buy |
+2,598,245
| New | +$42.1M | 0.01% | 1208 |
|
Other funds holding IMGN
State Street's IMGN Position: Q1 2024 in Review
State Street sold out of Immunogen Inc (IMGN) in Q1 2024, closing a stake of 8,075,671 shares — an estimated $239M sold.
State Street first reported a position in IMGN in Q2 2013 and held it in 43 quarters. The position peaked at $239M in Q4 2023. 3 funds tracked by Wall St. Rank hold IMGN as of Q1 2024.
- State Street reported no remaining Immunogen Inc position as of Q1 2024 after selling out during the quarter.
- State Street sold 8,075,671 Immunogen Inc shares in Q1 2024, an estimated $239M.
- State Street first reported a position in Immunogen Inc in Q2 2013 and held it in 43 quarters.
- State Street's Immunogen Inc position peaked at $239M in Q4 2023.
- 3 funds tracked by Wall St. Rank held Immunogen Inc as of Q1 2024.
Based on State Street's 13F filing for Q1 2024, filed 15 May 2024.